16 employees
InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.
2022
$8M
from 3 investors over 3 rounds
InnoSIGN raised $8M on March 22, 2022
Investors: Life Science Angels, Casdin Capital, LLC and Thuja Capital